Relmada Therapeutics (RLMD) Total Debt (2014 - 2019)
Relmada Therapeutics (RLMD) posted quarterly Total Debt of $110200.0 for Q4 2019, down 3.92% year-over-year from $114700.0 in Q4 2018, and down 56.94% quarter-over-quarter from $255900.0 in Q3 2019.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Total Debt (2014 - 2019) Analysis & Trends
Relmada Therapeutics (RLMD) has reported Total Debt for 6 consecutive years, with $110200.0 the latest figure, recorded in Q4 2019.
- In Q4 2019, Total Debt fell 3.92% year-over-year to $110200.0; the TTM figure through Dec 2019 stood at $110200.0 (down 3.92% YoY), while the FY2019 annual figure was $110200.0, changed N/A from the prior year.
- Total Debt slipped to $110200.0 in Q4 2019 per RLMD's latest filing, from $255900.0 in the prior quarter.
- Across five years, Total Debt topped out at $3.2 million in Q3 2018 and bottomed at $27600.0 in Q1 2017.
- Historically, Total Debt has averaged $428753.1 across 5 years, with a median of $216150.0 in 2015.
- Annual changes were most pronounced in 2017 — Total Debt soared 1061.55% — and 2019, when it plunged 91.99%.
- Relmada Therapeutics' Total Debt stood at $88500.0 in 2015, then increased by 24.29% to $110000.0 in 2016, then jumped by 1061.55% to $1.3 million in 2017, then tumbled by 91.02% to $114700.0 in 2018, then slipped by 3.92% to $110200.0 in 2019.
- Business Quant data shows RLMD's Total Debt at $110200.0 in Q4 2019, $255900.0 in Q3 2019, and $364200.0 in Q2 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 591.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1.07 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 9.34 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Relmada Therapeutics | 498.39 Mn | 498.39 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | 220,447.00 |
| Sep 30, 2019 | 511,825.00 |
| Jun 30, 2019 | 728,404.00 |
| Mar 31, 2019 | 57,569.00 |
| Dec 31, 2018 | 229,438.00 |
| Sep 30, 2018 | 7.71 Mn |
| Jun 30, 2018 | 6.85 Mn |
| Mar 31, 2018 | 5.53 Mn |
| Dec 31, 2017 | 4.96 Mn |
| Sep 30, 2017 | 3.20 Mn |
| Jun 30, 2017 | 553,370.00 |
| Mar 31, 2017 | 307,030.00 |
| Dec 31, 2016 | 633,505.00 |
| Sep 30, 2016 | 1.14 Mn |
| Jun 30, 2016 | 1.17 Mn |
| Mar 31, 2016 | 614,079.00 |
| Dec 31, 2015 | 1.53 Mn |
| Sep 30, 2015 | 4.88 Mn |
| Jun 30, 2015 | 14.27 Mn |
| Mar 31, 2015 | 24.47 Mn |